At Anchor Direct Primary Care, we have so very much to be thankful for. We have been open for 3 years now! We here at Anchor DPC cannot thank you enough for getting us to where we are. We are thrilled to continue to be able to serve our patients, addressing their medical needs.
Our patient base continues to grow. We are now actively seeking a medical assistant to join the practice to help us grow even more. This will enable further expansion of our capabilities, adding the option for on-site blood draws, increased patient coverage with even quicker response times, and some additional women’s health options.
As you all know, I value practicing medicine in an evidence based manner. I strive to work together with each patient to accurately diagnose any concern, while following evidence based guidelines, and partner with each patient in our decision-making to determine the best way to treat your unique situation.
Our priority remains providing full scope Family Medicine care to all our patients. As such, we are excited to announce the addition of two new medical devices to our clinic offerings! These devices complement our practice by adding new capabilities to treat some common conditions.
The first device is called the Emsella chair. This device uses high-intensity focused electromagnetic (HIFEM) technology to stimulate deep pelvic floor muscles and restore neuromuscular control to treat incontinence and sexual health. Patients stay fully clothed and sit on a chair for 6 sessions over the course of 3 weeks. It is FDA cleared to treat both men and women for urinary incontinence. It is so powerful, just one session is the equivalent of 12,000 Kegels. Research demonstrated that 95% of treated patients reported significant improvement in the quality of life.
The other device is called the Emsculpt Neo. This device also uses HIFEM to stimulate new muscle growth in the treated area, but it also uses synchronized radio-frequency (RF) to heat up the fat cells under the skin, causing permanent damage to the cells. A treatment consists of 4 weekly sessions. The Emsculpt Neo has FDA approval to treat the following areas:
While the obvious market for a device like this is aesthetics, we recognized that the value the Emsculpt Neo provides is more than skin-deep. The 30% permanent decrease in fat is a health benefit, as it not only hits the subcutaneous fat (right under the skin), but it also targets the visceral fat (around abdominal organs) which can be much more dangerous to long term health. The muscle growth is significant (up to 25%), which can be helpful for many patients such as the elderly (should help with mobility, fall prevention, and quality of life), those with a history of muscle asymmetry, and recovery from some sports and orthopedic injuries.
At this moment, we are working out the logistics of setting this all up. We have not yet set up pricing, though we expect there will be a discount for existing Anchor DPC members.
Thank you again for your support! As we move through the holiday season into the new year, we look forward to continuing to serve you as we work to provide excellence in your medical care.
Matthew Rensberry, MD
For the curious, learn more about how these devices work here: